Dutch Health Disruption: Reimagining Care with Social Entrepreneurship

By João L. Carapinha

July 1, 2025

The Dutch Health Disruption is a pressing issue that Michel van Schaik, Director of Healthcare at Rabobank, addresses in the June 2025 issue of Zorginstituut Magazine. He argues that the Dutch health system is fundamentally unsustainable due to escalating healthcare costs, chronic workforce shortages, and increasing demand. Van Schaik posits that these challenges cannot be rectified by existing sector players or through mere optimization of current systems. Instead, he advocates for breakthrough innovations emerging from outside traditional sectors. Drawing on Rabobank’s Sectorvisie Zorg and economist Joseph Schumpeter’s concept of “creative destruction,” he envisions a society by 2040 centered around citizen self-reliance and neighborhood solidarity, supported by new organizations.

The Case for Disruption: Systemic Challenges and External Innovation

Van Schaik’s core argument suggests that radical change cannot originate from current institutions, whose self-preserving tendencies limit transformation. Established providers and advocacy groups may seek only incremental improvements. Yet today’s challenges—such as chronic illness, widening health disparities, unsustainable costs, and insufficient staff—necessitate a new paradigm. He proposes a shift in focus from treatment toward well-being and prevention, positioning professional healthcare as a last resort. This model reinvigorates citizens’ collaboration within neighborhoods, echoing the historical concept of “noaberschap” (neighborliness). Notable examples include Rabobank’s support for local initiatives like fall prevention Health Impact Bonds, projects reducing pesticide use, and efforts encouraging healthier lifestyles.

Van Schaik claims that the “hindermacht” (obstructive power) of the current system often stifles new initiatives. He calls for regulatory and financial incentives to favor prevention and societal well-being over “paying for repair.” This would allow creative, socially motivated newcomers—irrespective of profit status—to flourish if they provide real value.

Van Schaik’s critique and vision resonate with recent global health sector trends and challenges. A 2025 Deloitte outlook notes that health systems worldwide face persistent staff shortages, budget constraints, and a need for efficiency and patient engagement. Over 70% of surveyed C-suite executives emphasize productivity, with many anticipating further workforce shortages, particularly among generalists.

In the U.S., 2025 data shows health care costs rising faster than inflation, compounded by workforce and spending complexities. Yet it’s widely acknowledged that medical care contributes little to health outcomes compared to social determinants like housing, income, and education. This reinforces Van Schaik’s assertion that only 10% of health and well-being derives from healthcare.

Moreover, community-based health approaches, including neighborhood support systems and “healthy urban living” projects, have been promoted by the WHO since 2023. Strengthening primary care, prevention, and community engagement is vital for bending the cost curve amid rising chronic disease and demographic changes.

Implications for Health Economics, Market Access, and Reimbursement: Toward Systemic Realignment

The implications of Van Schaik’s arguments are profound for health economics and policy. If most health outcomes are shaped by non-medical factors, reorienting investment toward prevention and social determinants could yield greater societal value. For payers and policymakers, this means supporting payment models prioritizing prevention and community-based solutions over care volume.

In terms of market access, new forms of value assessment and innovative contractinglike Health Impact Bonds—must be embraced to sustain social entrepreneurship. Regulatory frameworks should also evolve to create room for unconventional entrants and reduce procedural obstacles.

In conclusion, Van Schaik’s insights align with a growing consensus: sustainable health systems require adaptive, community-driven innovation backed by supportive incentives. Transitioning to this model demands financial creativity and a cultural shift in perceptions of health and societal responsibility. For more insights, explore the detailed magazine article.

Reference url

Recent Posts

patient experience data
           

Transforming Brain Health Innovation with Patient Experience Data: Strategic Insights for Health Economics

🧠 Are we truly listening to patients when innovating for brain health?

Recent insights underscore the importance of patient experience data (PXD) in shaping research and regulatory decisions around neurological disorders. By embedding PXD at every stage of healthcare innovation, we can align new therapies with what truly matters to patients, enhancing outcomes and access.

Dive into the transformative potential of patient-centered data and how it’s setting a new standard in health economics and outcomes research.

#SyenzaNews #HealthcareInnovation #HealthEconomics #MarketAccess

thimerosal vaccine removal
      

Thimerosal Vaccine Removal: HHS Finalizes Decision

🩺 Is the removal of thimerosal from flu vaccines a step towards safer immunization or a move that could undermine public trust?

The recent decision by the U.S. Department of Health and Human Services to eliminate this mercury-based preservative has sparked a heated debate. While aiming to protect vulnerable populations, it raises questions about the impact on public perception and vaccine confidence.

Dive into the implications of this controversial policy shift and what it means for the future of vaccination practices.

#SyenzaNews #HealthcarePolicy #HealthEconomics

type 2 diabetes treatment
       

Comprehensive Review of Type 2 Diabetes Treatment and Diagnosis Strategies

🤔 Are you up to date with the latest strategies for managing Type 2 Diabetes?

A recent comprehensive review jumps into the evolving landscape of Type 2 diabetes treatment, emphasizing individualized care through lifestyle modifications, effective medications, and emerging therapies. Discover how personalized approaches can not only improve health outcomes but also mitigate complications associated with this chronic condition.

Curious to learn more? Click through for insights that could transform your understanding of diabetes management!

#SyenzaNews #HealthcareInnovation #HealthEconomics

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER

© 2025 Syenza™. All rights reserved.